Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Biocept Inc (NASDAQ: BIOC)

$1.67 USD -$0.02 (-1.18%)
Last Price $1.67
Net Change $-0.02 (-1.18%)
Bid $1.6
Ask Price $2
Open Price $1.69
Previous Close Price $1.69
High Price $1.69
Low Price $1.6
Number of Trades 1,237
Volume 519,600
Fifty Two Week High $4.11 (2016-04-22)
Fifty Two Week Low $0.74 (2016-11-04)
Average Daily Volume 3,036,971
Share Outstanding 22,240 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $58.85
Recent Earnings $
Annual EPS $-2.19
Last Quarter EPS $
Market Capitalization $0.04B
Insider Shareholders % 0.068%
Annual Revenue $0B
No. Shares Outstanding 22,240
Inst. Shareholder % 4.59%
Annual Net Income $0B
TTM Net Profit Margin $100.17
1-Year Return -58.46%
3-Year Return -88.84%
5-Year Return -94.08%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 58.849998%
Dividends per Share $
Stock Split Ratio 1-3
Beta 3.01
Biocept, Inc. is a commercial stage oncology diagnostics company. It has developed technology platforms for capture and analysis of circulating tumor cells and circulating tumor DNA utilizing a standard blood sample to provide physicians. The company offers OncoCEE-BR (TM) test for breast cancer. Biocept, Inc. is headquartered in San Diego, California.